MN
ARLP
AGWA
JDJKMLPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Foghorntxfoghorntx.com SB  DDKW |
Foghorn Therapeutics is a biotechnology company pioneering a new class of medicines that correct abnormal gene expression by targe | Watertown, Massachusetts | 51-200 | — |
Agiosagios.com MT  BM SG |
Agios is a commercial-stage biopharmaceutical company developing therapies for people with rare diseases, with a near-term focus o | Cambridge, Massachusetts | 201-1000 | — |
Tenovabiotenovabio.com |
— | — | — | |
Syndax Pharmaceuticalssyndax.com  POCC EH |
Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies, with a pipeline incl | New York, New York | 201-1000 | — |
Mileutismileutis.com  JMIH DR |
— | — | — | |
Crispertherapeuticscrispertherapeutics.com |
— | — | — | |
CRISPR Therapeuticscrisprtx.com BLPP  DK |
CRISPR Therapeutics is a gene-editing biotechnology company pioneering CRISPR-based medicines, with CASGEVY™ — the first-ever appr | Boston, Massachusetts | 201-1000 | — |
Precisionbiosciencesprecisionbiosciences.com  CGMBES |
Precision BioSciences (Nasdaq: DTIL) is a clinical-stage gene editing company based in Durham, North Carolina, developing in vivo | Durham, North Carolina | 51-200 | — |
Intelliaintellia.com |
— | — | — | |
Editas Medicineeditasmedicine.com LB  AKJX |
Editas Medicine is a clinical-stage genome editing company that develops CRISPR-based medicines for serious diseases, with a pipel | Cambridge, Massachusetts | 51-200 | — |
Crisprcrispr.com |
— | — | — | |
Vervetherapeuticsvervetherapeutics.com |
— | — | — | |
Beamtherapeuticsbeamtherapeutics.com |
— | — | — | |
REGENXBIOregenxbio.com AK  ODBL |
REGENXBIO is a clinical-stage biotechnology company founded in 2008 and headquartered in Rockville, Maryland, pioneering AAV gene | Rockville, Maryland | 201-1000 | — |
Graphite Biographitebio.com  AL RZ |
Graphite Bio is a clinical-stage, next-generation gene editing company based in South San Francisco, California, pioneering the Ul | South San Francisco, California | 1-10 | — |
Logicbiologicbio.com |
— | — | — | |
Beam Therapeuticsbeamtx.com |
Beam Therapeutics is a CRISPR base editing biotechnology company founded in 2017 and headquartered in Cambridge, MA, developing a | Cambridge, Massachusetts | 201-1000 | — |
Pregenenbluebirdbio.com |
Genetix Biotherapeutics (formerly bluebird bio) is a privately held, Boston-area gene therapy company developing first-in-class, o | Seattle, Washington | 1-10 | — |
Homologymedicinehomologymedicine.com |
— | — | — | |
Cariboubiosciencescariboubiosciences.com |
— | — | — | |
Crisptherapeuticscrisptherapeutics.com |
— | — | — | |
| Run live for more | ||||
Foghorn Therapeutics is a biotechnology company pioneering a new class of medicines that correct abnormal gene expression by targeting disease dependencies within the chromatin regulatory system, using its proprietary Gene Traffic Control® platform.
Companies like Foghorn Therapeutics Inc. include Agios, Tenovabio, Syndax Pharmaceuticals, Mileutis, Crispertherapeutics. See the full list of 24 competitors and alternatives above.
Foghorn Therapeutics Inc. has approximately 51-200 employees and is in the Biotechnology Research industry.
Foghorn Therapeutics Inc. is headquartered in Watertown, Massachusetts.
Foghorn Therapeutics Inc. operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at Foghorn Therapeutics Inc. are listed above, including leaders across executive, finance, sales and operations.